P R E S S R E L E A S E

Essilor Annual General Meeting 2015

All resolutions approved

Dividend of 1.02€ per share

Marc Onetto appointed as a member of the Board of Directors

(Charenton-le-Pont, France, 5 May 2015) - Essilor International's Annual General Meeting was held today at the Palais des Congrès in Paris, chaired by Hubert Sagnières, the Group's Chairman and Chief Executive Officer.

Essilor's shareholders approved all of the resolutions put to the meeting, including the distribution of a dividend of 1.02 € per share for the 2014 financial year, which will be paid to shareholders from 21 May 2015.



The annual General Meeting also approved the appointment of Marc Onetto, 64, as new member of the Board of Directors for a period of 3 years.
An expert of operational efficiency and of excellence in service to customers, Marc Onetto, a French and American national, has held key positions major international companies. His competency in the area of internet sales and logistics will be a real asset for the Board of Directors.
After serving as Vice President Supply Chain for General Electric Medical Systems then Vice- President of General Electric Corporate European Operations, Marc Onetto joined Solectron - a global leader in electronics manufacturing- as Executive Vice President Worldwide Operations. Then, from 2006 to 2013, he was Senior Vice President of Worldwide Operations and Customer Service at Amazon.com, the world's largest e-retailer
He now dedicates his time in sharing the experience he gained during his international career path with top executives and academics.

CONTACTS

Investor Relations and Financial

Communication Véronique Gillet Sébastien Leroy Ariel Bauer

Tel.: +33 (0)1 49 77 42 16

Corporate Communication

Lucia Dumas

Tel.: +33 (0)1 49 77 45 02

Media Relations

Maïlis Thiercelin

Tel.: +33 (0)1 49 77 45 02



About Essilor

P R E S S R E L E A S E

The world's leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its mission is to improve lives by improving sight. To fulfill it, Essilor allocates more than

€180 million to research and innovation every year, in a commitment to continuously bringing new, more effective products to market. Its flagship brands are Varilux®, Crizal®, Transitions®, Definity®, Xperio®, Optifog™, Foster Grant®, Bolon®and Costa®. It also develops and markets equipment, instruments and services for eyecare professionals.

Essilor reported consolidated revenue of nearly €5.7 billion in 2014 and employs 58,000 people. It markets its products in more than 100 countries and has 33 plants, 490 prescription laboratories and edging facili ties, as well as several research and development centers around the world. For more information, please visitwww.essilor.com.

The Essilor share trades on the NYSE Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices. Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.

distributed by